China Resources Double-Crane Stock Hits Day High with 3.68% Surge

China Resources Double-Crane Pharmaceutical Co., Ltd. has seen a notable increase of 3.68% on July 1, 2026, reaching an intraday high of CNY 16.66. This performance stands in contrast to the China Shanghai Composite, which recorded a modest gain of 0.44% on the same day. Over the past week, the stock has shown a slight upward trend with a 1.03% increase, while its one-month performance reflects a decline of 1.54%. Year-to-date, the stock has faced challenges, with a decrease of 9.08%, significantly underperforming the broader market index, which has gained 3.62% in the same period. Despite the recent uptick, the company has experienced a decline of 10.93% over the past year, and its long-term performance remains below par, with a three-year return of -4.54%. The stock's current valuation metrics include a price-to-earnings ratio of 10.00 and a return on equity of 13.69%. The company maintains a dividend yield of 2.85%, reflecting its commitment to returning value to shareholders amidst fluctuating market conditions.